| Literature DB >> 31891300 |
Maureen George, Carme Hernandez, Sheree Smith, Georgia Narsavage, Mary C Kapella, Margaretann Carno, Jill Guttormson, Rebecca T Disler, Diana E Hart, Linda L Chlan, Mary Beth Happ, Zijing Chen, Breanna Hetland, Ana F Hutchinson, Helga Jonsdottir, Nancy S Redeker, Hildy Schell-Chaple, Monica Fletcher, Janelle Yorke.
Abstract
The objective of this workshop was to determine current nursing research priorities in critical care, adult pulmonary, and sleep conditions through input from consumer (patient, family, and formal and informal caregivers) and nursing experts around the world. Working groups composed of nurses and patients selected potential research priorities based on patient insight and a literature review of patient-reported outcomes, patient-reported experiences, and processes and clinical outcomes in the focal areas. A Delphi consensus approach, using a qualitative survey method to elicit expert opinion from nurses and consumers was conducted. Two rounds of online surveys available in English, Spanish, and Chinese were completed. A 75% or greater threshold for endorsement (combined responses from nursing and consumer participants) was determined a priori to retain survey items. A total of 837 participants (649 nurses and 188 patients, family, and/or caregivers) from 45 countries responded. Survey data were analyzed and nursing research priorities that comprise 23 critical care, 45 adult pulmonary, and 16 sleep items were identified. This project was successful in engaging a wide variety of nursing and consumer experts, applying a patient-reported outcome/patient-reported experience framework for organizing and understanding research priorities. The project outcome was a research agenda to inform, guide, and aid nurse scientists, educators, and providers, and to advise agencies that provide research and program funding in these fields.Entities:
Keywords: Delphi survey; nursing; nursing research priorities
Year: 2020 PMID: 31891300 PMCID: PMC6944344 DOI: 10.1513/AnnalsATS.201909-705ST
Source DB: PubMed Journal: Ann Am Thorac Soc ISSN: 2325-6621
Characteristics of nurse expert participants (Round 1 n = 412; Round 2 n = 237; N = 649*)
| Characteristics | Round 1 | Round 2 |
|---|---|---|
| Sex | ||
| Female | 362 (88) | 199 (84) |
| Male | 50 (12) | 38 (16) |
| Age, yr | ||
| <34 | 133 (34) | 53 (22) |
| 35–44 | 99 (24) | 64 (27) |
| 45–54 | 94 (22) | 66 (28) |
| 55+ | 62 (18) | 54 (23) |
| Nurse education | ||
| Postgraduate degree | 190 (44) | 127 (54) |
| University degree | 174 (44) | 92 (39) |
| Nursing degree from nonuniversity program | 37 (9) | — |
| Nurses employment | ||
| Full time in nursing | 249 (83) | 184 (78) |
| Part time in nursing | 26 (23) | 13 (5) |
| Care setting | ||
| Hospital | 260 (63) | 108 (46) |
| Academic/university | 56 (13) | 37 (16) |
| Primary care clinic | 22 (5) | 33 (14) |
| Specialty care clinic | 50 (12) | 32 (14) |
| Home care | 12 (3) | 16 (7) |
| Time employed as nurse, yr | ||
| <10 | 150 (39) | 51 (22) |
| 10–20 | 96 (23) | 57 (24) |
| 20+ | 151 (34) | 124 (52) |
| Time employed in specialty area, yr | ||
| <10 | 224 (54) | 99 (48) |
| 10–20 | 85 (21) | 73 (31) |
| 20+ | 71 (17) | 54 (23) |
| Received training in specialty area | ||
| Yes | 266 (65) | 133 (56) |
| No | 146 (35) | 104 (44) |
| Research experience in specialty area? | ||
| Yes | 158 (38) | 123 (52) |
| No | 254 (62) | 114 (48) |
Categories do not equal 100 due to missing responses and rounding.
Characteristics of patient and caregiver expert participants (Round 1, n = 154; Round 2, n = 34; N = 188*)
| Characteristics | Round 1 | Round 2 |
|---|---|---|
| Sex | ||
| Female | 134 (87) | 27 (79) |
| Male | 20 (13) | 7 (21) |
| Age, yr | ||
| <34 | 6 (4) | 7 (21) |
| 35–44 | 13 (8) | 7 (21) |
| 45–54 | 23 (15) | 5 (15) |
| 55+ | 113 (73) | 15 (44) |
| Patient/family/caregiver education | ||
| High school or less; trade school | 33 (21) | 6 (18) |
| Some college, no degree | 27 (17) | 9 (26) |
| University degree (2 or 4 yr) | 45 (29) | 9 (26) |
| Postgraduate degree | 41 (27) | 9 (26) |
| Patient/family/caregiver employment | ||
| Full-time work | 27 (17) | 19 (56) |
| Retired | 76 (49) | 8 (24) |
| Time since diagnosis/critical care stay, yr | ||
| <5 | 44 (28) | 13 (38) |
| 5–9 | 45 (29) | 6 (18) |
| 10–20 | 41 (27) | 8 (24) |
| 20+ | 16 (10) | 4 (12) |
Categories do not equal 100 due to missing responses or rounding.
Figure 1.Details are shown for countries. Size shows sum of Round 1 in blue and sum of Round 2 in yellow.
Nursing research priorities in critical care—final items endorsed by all nurses, patients, and caregivers
| Patient-reported outcomes |
| 1. Development and evaluation of interventions to reduce the incidence and/or duration of delirium |
| 2. Development and evaluation of assessment tools to identify dyspnea (breathlessness/ shortness of breath) |
| 3. Development and evaluation of interventions to manage dyspnea (breathlessness/ shortness of breath) |
| 4. Promotion of routine assessment of common symptoms, such as anxiety, thirst, breathlessness/dyspnea, and fatigue |
| 5. Development and evaluation of nonpharmacologic interventions to manage anxiety |
| 6. Development and evaluation of nonpharmacologic interventions to manage dyspnea (breathlessness/ shortness of breath) |
| 7. Describe relationships or clusters among critically ill patients’ symptoms (e.g., dyspnea, anxiety, pain, etc.) |
| 8. Describe the relationship between patient symptoms or experiences during critical illness and patient outcomes and recovery |
| 9. Description of fear (feeling scared) during critical illness |
| 10. Development and testing of nonpharmacologic interventions to manage pain or discomfort |
| 11. Evaluation of assessment tools to measure sleep during critical illness |
| 12. Evaluation of fatigue during critical illness |
| 13. Development and evaluation of nonpharmacologic interventions to improve sleep during critical illness |
| 14. Evaluation and description of emotional responses during critical illness such as anger, grief, or sadness |
| 15. Development of a pre-hospital discharge or pre-ICU discharge intervention or tool to identify potential challenges during recovery (e.g., decreased physical, psychosocial, or cognitive function) |
| 16. Identification and testing of interventions during acute hospitalization/ICU to improve recovery from critical illness (e.g., improve physical, psychosocial, cognitive, or quality-of-life outcomes) |
| 17. Identification and testing of interventions for after the ICU to improve recovery from critical illness (e.g., improve physical, psychosocial, cognitive, or quality-of-life outcomes) |
| 18. Evaluation and description of sleep disturbances during recovery from critical illness |
| 19. Evaluation and description of fatigue during recovery from critical illness |
| Patient-reported experiences |
| 1. Integration, into routine care, of interventions to enhance patient communication during mechanical ventilation |
| 2. Evaluation of patient outcomes related to communication ability during mechanical ventilation |
| 3. Identification and evaluation of communication/advocacy interventions to promote patient/family engagement and participation in decision-making |
| 4. Description and impact of patients’ feelings such as depersonalization, uncertainty, and vulnerability experienced during critical illness |
Definition of abbreviation: ICU = intensive care unit.
Nursing research priorities in adult respiratory health—final items endorsed by nurses, patients and caregivers
| Patient-reported outcomes |
| 1. Health-related quality of life (e.g., physical and mental health) |
| 2. Functional status (e.g., ability to perform normal daily activities to meet basic needs, fulfill usual roles, and maintain health and well-being) |
| 3. Symptom reduction (e.g., how patients can have fewer symptoms) |
| 4. Adherence (e.g., having closer agreement between what the patient wants to do for self-care and what they have been advised to do, such as taking medicines and quitting smoking) |
| 5. Quitting smoking and staying quit |
| 6. Risk reduction (e.g., identify what things will help decrease risk for a complication, a disease, or other unwanted outcomes) |
| 7. Patient education focused on risk reduction (e.g., teaching patients and families how to decrease risk for a complication, a disease, or other unwanted outcomes) |
| 8. Ways to motivate health promotion/health-seeking behaviors (e.g., enabling people to increase control over, and to improve, their health) |
| 9. Symptom overlap—better management strategies for symptoms that have multiple underlying causes (COPD and CHF exacerbation) |
| 10. Technology to support self-care (e.g., telehealth and home spirometry) |
| 11. Effective communication by the health care team (e.g., using plain language to explain diseases, medical tests, and treatments) |
| 12. Effective communication between patients and families and the health care team |
| 13. Personalized care (e.g., care that is tailored to help patients and families better understand the direction or course of their particular lung disease) |
| 14. Personalized care (understanding which models of care are appropriate and which treatments are effective at different time points across the trajectory of illness) |
| 15. Advance-care planning. This is a negotiated plan that tells the health care team what patients want for care if they are unable to speak for themselves. It is based on their own values, preferences, and discussions with their loved ones |
| 16. Anticipatory grief. This means learning how best to give patients and families bad news early and how best to respond to patient/family grief (e.g., refer to support groups or mental health specialists in end-of-life care) |
| 17. Presymptom management. This is the effectiveness of services aimed at preventing or slowing the development of lung disease or its symptoms (e.g., pulmonary rehab in early stage COPD) |
| 18. Low-cost simple treatments in places where resources are limited or unavailable (e.g., community walking programs instead of pulmonary rehab) |
| 19. Social support (e.g., helping friends/family to maximize quality outcomes in their loved ones) |
| 20. Nonpharmacologic interventions. These are ways to help patients with lung disease besides using medicines (e.g., pulmonary rehabilitation, psychological support, and handheld fans) |
| 21. Effectiveness of support groups early in progression (long-term impact on cost; online vs. face to face) |
| 22. Effectiveness of shared decision-making in improving outcomes |
| Patient-reported experience |
| 1. Quitting smoking and staying quit |
| 2. The impact of interventions that promote health |
| 3. How patients and families/caregivers make decisions about health |
| 4. The burden of having more than one illness |
| 5. Patients’ and families’/caregivers’ health beliefs |
| 6. How patients and families/caregivers think, understand, learn, and remember |
| 7. How patients and families/caregivers get, process, and understand basic health information and services to arrive at a health decision |
| 8. What families/caregivers understand about what patients need in order to take care of their disease or symptoms |
| 9. What patients and families/caregivers understand about the progression or prognosis of lung disease (e.g., will the symptoms get worse or will the disease never be cured?) |
| 10. What it is like for patients and families/caregivers to live with the uncertainty of what the future holds because of a lung disease diagnosis |
| 11. What it is like for patients and families/caregivers to create an advanced-care plan. This is a negotiated plan to tell the health care team what care they want if they are unable to speak. It is based on their values, preferences, and discussions with loved one |
| 12. What patients and families/caregivers have found to be helpful in motivating them to care for their disease or symptoms |
| 13. What it has been like for patients and families/caregivers to prepare for loss. This means responding to bad news (e.g., a disease cannot be cured or that symptoms will get worse) |
| 14. How families/caregivers can be helped to better understand what patients are experiencing |
| 15. What it is like for patients and families/caregivers to be diagnosed with a lung disease and to accept the diagnosis |
| 16. How much social support patients and families/caregivers have, or do not have, and how that impacts health |
| 17. How scientific evidence, patients’ and families’/caregivers’ values, preferences, and needs lead to certain health behaviors |
| 18. How patients and families/caregivers experience good and poor communication with the health care team |
| 19. The role of patients and patient associations in therapeutic education programs and caregiver support |
| 20. The impact of loneliness on outcomes in lung disease |
| To better understand the experience of the patient/family, nurses should: |
| 1. Use clinical data (e.g., emergency/hospitalization) in conducting research |
| 2. Conduct more longitudinal studies and more studies of greater length |
| 3. Use research frameworks like the chronic-care model (care) |
Definition of abbreviations: CHF = congestive heart failure; COPD = chronic obstructive pulmonary disease.
Nursing research priorities in sleep—final items endorsed by nurses, patients and caregivers
| Patient-reported outcomes |
| 1. Effective communication (what providers do with the information from the patients related to sleep) |
| 2. Adherence (agreement between patient preference and prescribed treatment of their sleep disorders or disturbances) |
| 3. Access (patient barriers to access care for sleep disorders or disturbances) |
| 4. Trajectory (how the need for sleep assessment and treatment changes over the course of a chronic illness) |
| 5. Risk reduction (how sleep disorders or disturbances influence the trajectory of the chronic illness) |
| 6. Functional status (how sleep disturbances affect other symptoms, such as problems breathing and the ability to do valued daily activities) |
| 7. Prevention (whether a change in sleep pattern comes before or signals an acute exacerbation of a lung disease) |
| 8. Access (level of access to sleep care) |
| 9. Self-management (knowledge and technology skills to support sleep health) |
| 10. Sleep health education (evidence-based education for patients and providers) |
| 11. The use of technology/telehealth to support the diagnosis and treatment of sleep conditions |
| 12. The use of population health information for the identification of those with undiagnosed sleep conditions |
| Patient-reported experiences |
| 1. Psychological support that is needed for sleep conditions |
New item added after analysis of open responses.